Press Releases

Advarra debuts Braid™ to unlock operational intelligence and workflow automation in clinical trials through AI

Powered by the industry’s largest set of digitized protocols and operational data, Braid enables smarter trial design and greater operational efficiency

CapeStart Expands Operations with New Office in Chennai to Support AI Center of Excellence

With goal of delivering reliable AI solutions for life sciences companies, CapeStart continues to build out GenAI expertise, services, and the MadeAi™ platform

Arcinova Appoints Christian Dowdeswell as New Managing Director

Global healthcare AI experts and former UK Health Minister back AI that detects healthcare-associated infections up to 72 hours earlier

VieCure Expands Community Oncology Care Network with Addition of Summit Cancer Centers

VieCure adds Summit Cancer Centers to community oncology care network

Advarra appoints Brian Hart as Chief Technology Officer

Former Covera Health CTO to lead technology and product strategy at Advarra, driving innovation in clinical research

Emerald Clinical Trials Confirms CEO Transition and Continuity Plan

MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology

MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology

Symbiosis Reaches Major Milestone with 1,000th Batch of Injectable Drug Product

Sygnature Discovery Completes Major Enhancement of High-Throughput Chemistry Facilities Following £1 Million Investment

MIT Deploys Openwater’s Open-LIFU to Advance Neuroscience Research

MIT’s Lincoln Laboratory is first to receive the latest version of the device, with the goal to use low-intensity focused ultrasound to support its research exploring conscious perception.

Hoosier Cancer Research Network Report Reveals Key Trends Shaping Investigator-Initiated Oncology Trials

Hoosier Cancer Research Network has released a new report, “Investigator-Initiated Oncology Trials: Trends, Challenges, and Opportunities,” that captures the experience and perspectives of more than 130 researchers across its nationwide network. The findings highlight key trends shaping investigator-initiated oncology research and the operational, institutional, and funding challenges researchers face in today’s environment.

START and Advarra Unite to Deliver Unmatched Speed, Quality, and Predictability for Early-Phase Oncology Trials

START enhances its global leadership by integrating Advarra’s advanced regulatory and technology solutions, creating a seamlessly connected site network to accelerate trials and relieve pressure on the oncology drug development ecosystem.

Abzena Appoints Geoffrey M. Glass as Chief Executive Officer

Uniphar Rebrands On Demand Business to Uniphar Global Sourcing, Strengthening Global Pharmaceutical Offering

Sharp's Emissions Reduction Targets Validated by Science Based Targets initiative

Quotient Sciences Announces Formation of Scientific Advisory Board

Yourgene Health Launches LightBench Discover

Three-in-one system integrates large fragment analytics, DNA size selection and fluorometric quantification for long-read sequencing

Hongene Supports Clinical Advancement of siRNA DNV001 Using Proprietary Chemoenzymatic Ligation Platform

ClearNote Health Receives First In Vitro Diagnostic Approval for its Avantect® Pancreatic Cancer Test

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced that it has received UK Conformity Assessed (UKCA) marking for its Avantect® Pancreatic Cancer Test. The UKCA mark, established as part of the United Kingdom’s independent product safety regulatory framework following its departure from the European Union, signifies compliance with UK medical device regulations and paves the way for commercial availability in the UK market.